Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Identifying and validating genetic predictors of morphine-related harm and ineffectiveness in children

EF 2022-23

Résumé
Morphine is a commonly used opioid in children to help relieve pain. However, responses to morphine vary enormously between individuals due to genetic differences, resulting in challenges to provide adequate dosing and minimize side effects. Children can experience morphine-related side effects and ineffectiveness due to genetic differences that influence how morphine is processed and transported within body as well as genetic differences that impact cellular pathways involved in pain responses. Many genes have already been investigated for their influences on variable morphine responses in children. However, most findings still need to be assessed in additional children and further investigated using pain management models to understand how/if genetic variants consistently contribute to variable morphine responses. Therefore, this research project aims to identify and explore the roles of genetic factors involved in variable morphine responses in children. To accomplish this objective, a systematic review will first be conducted to identify genetic factors already found to be associated with variable morphine responses in the literature. Then this project will determine if the genetic variants identified in the literature are associated with morphine responses in paediatric patients recruited through the BC Children's Hospital Research Institute. Finally, a pain management model will be developed using nematode (i.e., worm) to investigate the biological roles of genetic variants in morphine responses. Ultimately, the research project will lead to the incorporation of genetic findings into updated clinical practice recommendations to inform precision medicine guidelines that aim to improve morphine-based pain management.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485891
Name
Zhang Jia He
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying and validating genetic predictors of morphine-related harm and ineffectiveness in children
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Drug Reactions; Genetic Variants; Genomics; Molecular Genetics; Morphine; Pain Management; Pediatrics; Pharmacogenomics; Precision Medicine
Abstract
Morphine is a commonly used opioid in children to help relieve pain. However, responses to morphine vary enormously between individuals due to genetic differences, resulting in challenges to provide adequate dosing and minimize side effects. Children can experience morphine-related side effects and ineffectiveness due to genetic differences that influence how morphine is processed and transported within body as well as genetic differences that impact cellular pathways involved in pain responses. Many genes have already been investigated for their influences on variable morphine responses in children. However, most findings still need to be assessed in additional children and further investigated using pain management models to understand how/if genetic variants consistently contribute to variable morphine responses. Therefore, this research project aims to identify and explore the roles of genetic factors involved in variable morphine responses in children. To accomplish this objective, a systematic review will first be conducted to identify genetic factors already found to be associated with variable morphine responses in the literature. Then this project will determine if the genetic variants identified in the literature are associated with morphine responses in paediatric patients recruited through the BC Children's Hospital Research Institute. Finally, a pain management model will be developed using nematode (i.e., worm) to investigate the biological roles of genetic variants in morphine responses. Ultimately, the research project will lead to the incorporation of genetic findings into updated clinical practice recommendations to inform precision medicine guidelines that aim to improve morphine-based pain management.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Jia He
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~